EcoDrugPlus

Ribosomal Protein L17

Ensembl ID : ENSCSEG00000020536
Gene Symbol: RPL17
3 Cross references
308 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSCSEG00000004760
Gene Symbol: RPL17
1 Cross references
302 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCSEG00000003962
Gene Symbol: RPL18A
3 Cross references
367 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSCSEG00000016515
Gene Symbol: RPL21
3 Cross references
783 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCSEG00000018142
Gene Symbol: RPL22
3 Cross references
369 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSCSEG00000013885
Gene Symbol: RPL23
3 Cross references
210 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSCSEG00000010060
Gene Symbol: RPL23A
3 Cross references
819 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSCSEG00000004049
Gene Symbol: RPL24
3 Cross references
318 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSCSEG00000001155
Gene Symbol: RPL27A
4 Cross references
510 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSCSEG00000001312
Gene Symbol: RPL28
3 Cross references
283 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSCSEG00000010267
Gene Symbol: RPL29
3 Cross references
505 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSCSEG00000017333
Gene Symbol: RPL30
3 Cross references
318 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).